Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,515 USD | -2,52% | +1,44% | +178,12% |
12/03 | Sectorupdate: Gezondheidszorgaandelen stijgen laat in de middag | MT |
12/03 | Sectorupdate: Aandelen gezondheidszorg hoger in middaghandel | MT |
Vakgebied
Aantal werknemers: 486
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 141 | 100,0 % | 148 | 100,0 % | +4,99% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
74,0
%
| 85 | 60,1 % | 109 | 74,0 % | +29,24% |
Japan
10,7
%
| 10 | 6,9 % | 16 | 10,7 % | +62,51% |
United States
8,8
%
| 13 | 8,9 % | 13 | 8,8 % | +3,53% |
Europe
6,5
%
| 34 | 24,0 % | 10 | 6,5 % | -71,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thane Wettig
CEO | Chief Executive Officer | 59 | 22-06-20 |
Juan Graham
DFI | Director of Finance/CFO | 48 | 07-09-21 |
James Schoeneck
CHM | Chairman | 66 | 01-04-10 |
Chief Tech/Sci/R&D Officer | - | - | |
John Hunter
CTO | Chief Tech/Sci/R&D Officer | 61 | 12-07-21 |
Elias Kouchakji
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-01-14 |
Meichiel Keenan
IRO | Public Communications Contact | - | 01-05-04 |
David DeLucia
IRC | Investor Relations Contact | - | - |
Tricia Stewart
HRO | Human Resources Officer | - | 01-05-21 |
Corporate Officer/Principal | 56 | 01-01-07 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Edwards
BRD | Director/Board Member | 64 | 28-10-15 |
Director/Board Member | 59 | 06-08-15 | |
May Kin Ho
BRD | Director/Board Member | 71 | 06-12-18 |
Benjamin Cravatt
BRD | Director/Board Member | 54 | 05-08-20 |
Gerald Lema
BRD | Director/Board Member | 63 | 19-09-17 |
James Schoeneck
CHM | Chairman | 66 | 01-04-10 |
Suzanne Blaug
BRD | Director/Board Member | 66 | 05-06-19 |
Aoife Brennan
BRD | Director/Board Member | 48 | 05-08-20 |
Thane Wettig
CEO | Chief Executive Officer | 59 | 22-06-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 98 771 247 | 92 481 524 ( 93,63 %) | 0 | 93,63 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+178,12% | 255 mln. | |
+8,86% | 45,97 mld. | |
+53,12% | 43,93 mld. | |
+9,90% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+17,41% | 27,18 mld. | |
-20,23% | 19,44 mld. | |
+13,74% | 13,83 mld. | |
+31,43% | 12,4 mld. | |
+8,91% | 11,45 mld. |
- Beurs
- Aandelen
- Aandeel FibroGen, Inc. - Nasdaq
- Onderneming FibroGen, Inc.